Touchlight is a UK-based biotechnology company leading advancements in enzymatic DNA production, enabling innovations across the genetic medicine landscape.

Touchlight is headquartered in Hampton, UK, and specialises in its proprietary doggybone DNA (dbDNA™) technology. This synthetic DNA platform addresses the needs of gene therapy, DNA vaccines, and other genetic medicine applications. By replacing traditional bacterial processes with enzymatic techniques, Touchlight achieves faster, scalable, and high-purity DNA production.

Key Products and Services

• dbDNA™ Technology: Synthetic, bacterial-free DNA vectors.
• Preclinical Services: Research-grade and toxicology materials.
• GMP Supply: DNA for clinical and commercial use.
• Development Services: Analytical development, scale-up, and formulation.
• Regulatory Support: Guidance for compliance in genetic medicine.

Touchlight’s innovative approach empowers rapid development in genetic therapeutics, supporting partners worldwide to meet growing demands in precision medicine.